Cite

HARVARD Citation

    Reddel, S. et al. (2019). Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) study. Multiple sclerosis. pp. 1124-1131. [Online]. 
  
Back to record